Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart sensors could revolutionize ICU blood sugar management

NCT ID NCT05585801

Disease control Sponsor: Institute for Clinical and Experimental Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether continuous glucose monitors (CGMs) can help ICU patients maintain safe blood sugar levels more effectively than standard finger-stick checks. Researchers will enroll 500 adults undergoing major surgeries like pancreas or liver transplants. The goal is to see if CGMs reduce time spent outside the target glucose range and ease the workload on nurses.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dexcom G6 continuous glucose monitor
What this could lead to
If successful, this could show that continuous glucose monitors are reliable and effective for managing blood sugar in ICU patients, potentially becoming a new standard of care.
What could go wrong
This is a single-center study with 500 patients, and results may not apply to all ICU settings. The device's accuracy in critically ill patients is still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2022

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male or female patients, of 18 to 80 years of age, undergoing one of the following surgical procedures and post-operative care at ICU: 1. pancreas surgery - total or partial pancreas resection 2. orthotopic liver transplantation 3. simultaneous pancreas and kidney transplantation 4. patients with diabetes mellitus undergoing major surgery 2. Patient must have signed the Patient Informed Consent Form. Exclusion Criteria: Any criteria that would disable surgical procedures involved

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood glucose are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood glucose Critical care

Contacts and locations

Locations

  • Institute for Clinical and Experimental Medicine

    Prague, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.